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Introduction
•

Trimethoprim-sulfamethoxazole allergy can complicate treatment for

Results
•

•

Eleven patients were identified who underwent trimethoprim-

Trimethoprim-sulfamethoxazole hypersensitivity is infrequently

various infections. While trimethoprim-sulfamethoxazole

sulfamethoxazole skin testing and/or oral challenge. Two reactions

evaluated in the Pediatrics. However, trimethoprim-

hypersensitivity, desensitization/oral challenges are frequently

were consistent with an IgE-mediated process while the remainder

sulfamethoxazole is an effective antibiotic and reported allergy

reported in adults, data is limited on the outcomes/safety of oral

were non-IgE-mediated/indeterminate. Two underwent skin testing to

limits treatment for infections. Evaluation of the initial reaction is

challenges to trimethoprim-sulfamethoxazole in Pediatrics. The goal of

trimethoprim-sulfamethoxazole; both negative. Ten patients

necessary, as many patients have non-IgE-mediated/indeterminate

this study was to characterize the outcomes and safety of

underwent successful oral challenge to trimethoprim-

reactions. Severe cutaneous adverse reactions should be evaluated

trimethoprim-sulfamethoxazole oral challenges in Pediatrics.

sulfamethoxazole; the eleventh patient was lost to follow-up after skin

for when considering candidates for oral challenge to trimethoprim-

testing.

sulfamethoxazole as oral challenge is contraindicated in these
Reaction history prior to challenge

Methods

6

An IRB-exempt retrospective chart review was performed of pediatric

characteristics including age, sex, reaction (IgE-mediated/non-IgEmediated/indeterminate), skin testing, challenge outcome and

complications to draw a conclusion regarding the overall safety of the
procedure in the pediatric population.

trimethoprim-sulfamethoxazole is a safe procedure to perform in

maculopapular/non-urticarial
exanthem

select pediatric patients and can be done safely in the outpatient
Urticaria

patients who underwent oral challenge to trimethoprimsulfamethoxazole in Allergy Clinic over the last 12 years. We assessed

patients. Overall, this study demonstrated that oral challenge to
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Number of cases

•

Conclusion
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Female
Male

3
2
1

0

Syncope, globus
sensation

setting. One limitation was small sample size.

